Repligen | RGEN - Loan Capital

Stock Price
142.99
Daily Change
3.33 2.38%
Monthly
-15.42%
Yearly
-8.37%
Q1 Forecast
144.77

Repligen reported $537.93M in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
Agilent USD 3.05B 300M Sep/2025
Align Technology USD 0 0 Dec/2024
Bio Techne USD 260M 40M Dec/2025
BioMarin Pharmaceutical USD 596.66M 501K Sep/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
Bruker USD 1.98B 395.4M Sep/2025
Charles River Laboratories USD 2.19B 146.92M Sep/2025
Danaher USD 18.42B 1.58B Dec/2025
Dentsply International USD 2.02B 201M Sep/2025
Exact Sciences USD 2.33B 9.34M Sep/2025
General Electric Aerospace USD 18.81B 37M Dec/2025
Henry Schein USD 2.15B 63M Sep/2025
Illumina USD 1.49B 496M Dec/2025
IQVIA Holdings USD 13.88B 1.09B Dec/2025
Mettler Toledo International USD 2.09B 58.01M Dec/2025
Myriad Genetics USD 119.5M 60.2M Sep/2025
Pfizer USD 57.41B 93M Sep/2025
Repligen USD 537.93M 4.2M Sep/2025
Revvity USD 2.63B 583.63M Sep/2025
Standard Biotools USD 299K 0 Sep/2025
Thermo Fisher Scientific USD 35.85B 4B Dec/2025
Waters USD 947.21M 249.76M Sep/2025
West Pharmaceutical Services USD 202.7M 100K Sep/2025